DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Rini BI, Stein M, Shannon P et al.
Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma.
Cancer 2011;
117: 758-767
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.